• Press release
Aug 10, 2020
Mariposa Therapeutics secures pre-seed funding led by Neem Biotech and EB Research Partnership

Recent Welsh biotech spin out Mariposa Therapeutics Ltd. has secured pre-seed funding led by Neem Biotech and EB Research Partnership. 

EB Research Partnership is the largest global non-profit dedicated to funding research to find a cure for Epidermolysis Bullosa (EB). They fund using their Venture into Cures methodology; We find the most promising research projects. We vet them through our world-class scientific advisory board. Then, in exchange for funding them, we take a financial interest in the work of the university or business. When those projects succeed, we reinvest the returns from our shares back into other promising EB research projects. 

Mariposa is excited to have EBRP and Neem Biotech on board, both in terms of the financial investment and the additional expert support and network that they provide. The funds will be used to generate key data on their novel compounds to identify a lead candidate for development.